Wilmington, DE -- (SBWIRE) -- 09/10/2013 -- Equity Profile Report expands its NASDAQ Active Stock Weekly Watch List adding DryShips, Inc. (NASDAQ:DRYS) and Arena Pharmaceuticals, Inc. (NASDAQ:ARNA).
DryShips, Inc. (NASDAQ:DRYS) a company that owns drybulk carriers and tankers that operate worldwide closed up in its previous session (+7.12%) on 35,400,091 shares traded as DryShips Remained Neutral. DryShips, Inc. (NASDAQ:DRYS) is currently up (+115.07%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.
Click Here to find out what other Investors are saying about DryShips, Inc. (NASDAQ:DRYS)
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) a biopharmaceutical company that engages in discovering, developing, and commercializing novel drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases closed down in its previous session (-1.10%) on 4,110,543 shares traded after Arena Pharmaceuticals announced to Present at the Bank of America Merrill Lynch Global Healthcare Conference. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) is currently down (-43.09%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.
Click Here to find out what other Investors are saying about Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.Equityprofilereport.com
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.
Equity Profile Report
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)